15.02.2013 Views

world cancer report - iarc

world cancer report - iarc

world cancer report - iarc

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Certain Possible Uncertain<br />

Age Androgens Body size<br />

High fat diet Race Sexual activity<br />

Family history Estrogens Vasectomy<br />

The distribution of mortality rates is less<br />

affected than incidence by the effects of<br />

early diagnosis of asymptomatic <strong>cancer</strong>s<br />

(whether through screening, or by detection<br />

of latent <strong>cancer</strong> in tissue removed during<br />

prostatectomy operations). Mortality<br />

rates are comparatively high in North<br />

America, Northern and Western Europe,<br />

Australia/New Zealand, parts of South<br />

America (Brazil) and the Caribbean, and in<br />

much of sub-Saharan Africa and low in<br />

Asian populations, and in North Africa (Fig.<br />

5.46). The difference in mortality between<br />

China and the USA is 26-fold (while it is<br />

almost 90-fold for incidence). Racially<br />

based differences are evident within the<br />

United States, where the black population<br />

has the highest incidence (and mortality)<br />

rates, those rates being some 35% higher<br />

250<br />

100<br />

50<br />

25<br />

10<br />

5<br />

2.5<br />

1<br />

Japan<br />

1960197019801990 2000<br />

250<br />

100<br />

50<br />

25<br />

10<br />

5<br />

2.5<br />

1<br />

Selenium Vitamin A<br />

Vitamin E/D Calcium<br />

Phyto-estrogens Lycopene<br />

Table 5.8 Risk and protective (in italics) factors for prostate <strong>cancer</strong>.<br />

Singapore<br />

1960197019801990 2000<br />

than in whites, who in turn have rates considerably<br />

higher than populations of Asian<br />

origin (Chinese, Japanese, Korean).<br />

Etiology<br />

Age is the strongest risk factor for prostate<br />

<strong>cancer</strong>. Development of this malignancy is a<br />

multi-step process associated with a long<br />

natural history [2]. It can be inferred that<br />

the initiation of preneoplastic lesions and<br />

microscopic <strong>cancer</strong> is influenced by environmental<br />

factors which, in turn, implies a<br />

case for lifestyle causes and primary prevention.<br />

Although many of the risk factors for adenocarcinoma<br />

of the prostate (Table 5.8) are<br />

weakly linked, the strong association of<br />

race, familial and geographic patterns with<br />

mortality directs attention to a significant<br />

250<br />

100<br />

50<br />

25<br />

10<br />

5<br />

2.5<br />

1<br />

USA<br />

Black<br />

White<br />

1960197019801990 2000<br />

Australia<br />

role for genetic-environmental interactions<br />

as determining patterns of disease. Dietary<br />

patterns suggest that saturated fat is a significant<br />

risk factor, while micronutrients<br />

such as the vitamins A, E and D, selenium,<br />

lycopene and calcium may exercise a protective<br />

effect against <strong>cancer</strong>.<br />

The role of hormones, especially androgens,<br />

is obviously important, granted the impact<br />

of orchidectomy (excision of the testes) on<br />

progression. However, an endocrine basis<br />

for carcinogenesis is still not well understood.<br />

Genetic polymorphisms in the androgen<br />

receptor may be more important than<br />

any imbalance of hormones in the circulation.<br />

Studies of body size, vasectomy, sexual<br />

activity and cigarette smoking as risk factors<br />

have produced inconclusive, equivocal<br />

results.<br />

A diet characteristic of Asian countries such<br />

as Japan and China, essentially a low fat<br />

intake with consequent low body weight,<br />

with an intake of relatively high levels of<br />

phyto-estrogens (Box: Phyto-estrogens,<br />

p78) may provide the means of restraining<br />

the growth and progression of prostate <strong>cancer</strong>.<br />

A strategy for prevention would be to<br />

increase the intake of phyto-estrogens,<br />

essentially isoflavonoids, lignans and possibly<br />

certain flavonoids [3]. The years of<br />

potential life saved by preventive measures<br />

for prostate <strong>cancer</strong> may be less than for<br />

<strong>cancer</strong>s occurring earlier in life, but the<br />

number of men with the disease <strong>world</strong>wide<br />

adequately justifies a focus on this effort<br />

(Screening for prostate <strong>cancer</strong>, p160).<br />

Fig. 5.46 Trends in prostate <strong>cancer</strong> mortality. Although mortality rates increased generally in the last 30 years, in some places, e.g. the USA, mortality is now<br />

falling. D.M. Parkin et al. (2001) Eur J Cancer, 37 Suppl.8: S4-66.<br />

250<br />

100<br />

50<br />

25<br />

10<br />

5<br />

2.5<br />

1<br />

1960197019801990 2000<br />

250<br />

100<br />

50<br />

25<br />

10<br />

5<br />

2.5<br />

1<br />

Poland<br />

1960197019801990 2000<br />

250<br />

100<br />

50<br />

25<br />

10<br />

5<br />

2.5<br />

1<br />

Spain<br />

1960197019801990 2000<br />

Cancers of the male reproductive tract 209

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!